# Jeff Hurst

> Jeff Hurst is a Series C investor at Commonwealth Capital Ventures backing Analytics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Commonwealth Capital Ventures](https://shizune.co/investors/profile/commonwealth-capital-ventures)
- Total investments: 3
- Last investment: Mar 2010
- Lead investor: 0%
- Last updated: Aug 2026

Jeff Hurst is a Series C investor at Commonwealth Capital Ventures focused on Analytics and Life Science. Jeffrey M. Hurst is a general partner and a co-founder of Commonwealth Capital Ventures. Before co-founding Commonwealth in 1995, Jeff was a senior vice president with GE Capital's Corporate Finance Group. Jeff previously served as a managing partner of Cox Partners, a private equity firm, after starting his career with Bankers TrustCompany.Jeff earned a BA in History and Economics from Duke University and an MBA from Tulane University. Jeff is also a member of the Trinity College Board of Visitors of Duke University.Current Investments * BBN Technologies * ByAllAccounts * Copanion * Crossbeam Systems * First Coverage * Seahorse * Swissray * Tungle * Visible AssetsSelected Prior Investments * American Internet Corp. (Acquired by Cisco Systems) * NBX (Acquired by 3COM) * Neurometrix (NASDAQ: NURO) * The MacGregor Group (Acquired by Investment Technology Group)

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Analytics | 1 | 33% |
| Life Science | 1 | 33% |
| Biotechnology | 1 | 33% |
| Manufacturing | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 1 | 33% |
| Series D | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Seahorse Bioscience | Seahorse Bioscience provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company's customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers. | $5M | Series D | Mar 08, 2010 |  |
| Seahorse Bioscience | Seahorse Bioscience provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company's customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers. | $6M | Series D | Mar 09, 2009 |  |
| Seahorse Bioscience | Seahorse Bioscience provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company's customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers. | $11.5M | Series C | Feb 01, 2005 |  |

3 of 3 investments shown.

## Co-investors
- [Flagship Pioneering](https://shizune.co/investors/profile/flagship-ventures) — VC Fund, 2 deals together
- [HealthCare Ventures](https://shizune.co/investors/profile/healthcare-ventures) — VC Fund, 2 deals together
- [HLM Venture Partners](https://shizune.co/investors/profile/hlm-venture-partners) — VC Fund, 2 deals together
- [New Science Ventures](https://shizune.co/investors/profile/new-science-ventures) — VC Fund, 2 deals together
- [Oxford Bioscience Partners](https://shizune.co/investors/profile/oxford-bioscience-partners) — VC Fund, 2 deals together
- [Rock Maple Ventures](https://shizune.co/investors/profile/rock-maple-ventures) — VC Fund, 2 deals together

## About Commonwealth Capital Ventures

VC Fund · Boston, United States

Commonwealth Capital Ventures is a leading venture capital firm focused on early and growth stage technology companies. Their experienced professionals empower management teams to build outstanding growth companies that deliver superior returns to investors. As true partners, they work beside their entrepreneurs with the patience needed tobuild successful businesses.With more than $580 million of committed capital under management, the firm’s partners have invested in roughly 140 high-growth companies, many of which are leaders in their respective industry categories. Their limited partners are highly sophisticated venture investors and include leading educational and financial institutions, pension funds, and family offices. They are aligned with their investors in providing patient capital with a view toward long-term success. Their current $250 million fund closed in early 2007 and is appropriately sized to focus on early stage opportunities and later stage venture growth enterprises.

5 contacts available at Commonwealth Capital Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Cheryl A. Kerrigan | Assistant Treasurer and Business Office Manager | https://shizune.co/investors/profile/cheryl-a-kerrigan |
| Elliot Katzman | General Partner | https://shizune.co/investors/profile/elliot-katzman |
| Jeff Hurst | Founder, General Partner | https://shizune.co/investors/profile/jeff-hurst |
| Michael Fitzgerald | Founder, Managing General Partner | https://shizune.co/investors/profile/michael-fitzgerald-2 |
| Nate Loewentheil | Founder & Managing Partner | https://shizune.co/investors/profile/nate-loewentheil |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Jeff Hurst invest in?

Jeff Hurst invests primarily in Analytics, Life Science and Biotechnology startups, most often at Series C and Series D stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jeff Hurst last invest?

The most recent investment recorded for Jeff Hurst closed in Mar 2010. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co